WSTWest Pharmaceutical Services, Inc.Healthcare · Medical - Instruments & Suppliesas of 2026-09-16
Horizon

Issued 2026-09-16 at $362.01 · now $362.01 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, WST has typically landed between $306.97 and $416.85 — a range of −15.2% to +15.2% from the issuance price $362.01.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($362.01) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where WST has typically landed a month from the 2026-09-16 close of $362.01 — the range is history, not a prediction.

$306.97worst · -15.2%$416.85best · +15.2%
  • now $362.01 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $365.35 (+0.9%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $345.1–$385.6
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $306.97–$416.85
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,685 windows spanning 2008-01-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-01-21−40.9%−42.2%+0.9%
2025-01-17−39.8%−40.8%+3.4%
2025-01-14−39.4%−39.4%+5.7%
3 best
2020-03-25+44.6%+0.0%+44.6%
2020-03-24+38.5%−0.1%+38.5%
2020-03-27+36.9%+0.0%+40.4%

4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked

Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.

$23.1B
market cap
$7.82
EPS (TTM)
42.0
P/E (TTM)
2026-10-22
next earnings
Revenue$3.1B
'20'25
Net income$494M
'20'25
Free cash flow$469M
'20'25
Net margin · by yr16.1%
'20'25
ROE · by yr15.5%
'20'25
Debt / equity · by yr0.13
'20'25

Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.

iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 54 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.
now $362.01$63.26$475.43
  • DCF (intrinsic)$91.68
  • Peer P/E × EPS · sector median 27.4× · n=54$214.58
  • Analyst target · range $295.00–$447.00$377.50
  • Current price · last close 2026-09-16$362.01

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
−0.4%
n=18
Feb
47%
−0.4%
n=19
Mar
79%
+4.6%
n=19
Apr
63%
+3.1%
n=19
May
53%
+1.4%
n=19
Jun
68%
+2.7%
n=19
Jul
63%
+4.1%
n=19
Aug
68%
+1.4%
n=19
Sep
47%
−0.1%
n=19
Oct
67%
+1.0%
n=18
Nov
72%
+1.9%
n=18
Dec
67%
+1.0%
n=18

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$366$2312026-09-15: 1 insider sale, $921K — Favorite Annette F2026-09-14: 1 insider sale, $888K — Favorite Annette F2026-09-11: 1 insider sale, $863K — Favorite Annette F2026-09-08: 3 insider sales, $2.8M — Favorite Annette F …2026-04-27: 2 insider sales, $1.1M — Favorite Annette F, Winters Chad2026-04: 2 open-market sales, $1.1M2026-09: 6 open-market sales, $5.4M↑ buys↓ salesofficer Favorite Annette F — Sale on 2026-09-15, filed same dayofficer Favorite Annette F — Sale on 2026-09-14, filed 1 day after the tradeofficer Favorite Annette F — Sale on 2026-09-11, filed 4 days after the tradeofficer Favorite Annette F — Sale on 2026-09-08, filed 2 days after the tradeofficer Favorite Annette F — Sale on 2026-09-08, filed 2 days after the tradeofficer Favorite Annette F — Sale on 2026-09-08, filed 2 days after the tradeofficer Favorite Annette F — Sale on 2026-04-27, filed 2 days after the tradeofficer Winters Chad — Sale on 2026-04-27, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-09-15Favorite Annette FofficerSale2,524 @ $365.00$921K−10.4% of holdingnot yet — horizon still opennot yet — horizon still open21,818Form 4 · filed same day
2026-09-14Favorite Annette FofficerSale2,500 @ $355.00$888K−10.3% of holdingnot yet — horizon still opennot yet — horizon still open21,818Form 4 · filed 1 day after the trade
2026-09-11Favorite Annette FofficerSale2,500 @ $345.00$863K−10.3% of holdingnot yet — horizon still opennot yet — horizon still open21,818Form 4 · filed 4 days after the trade
2026-09-08Favorite Annette FofficerSale2,818 @ $340.81$960K−14.3% of holdingnot yet — horizon still opennot yet — horizon still open16,845Form 4 · filed 2 days after the trade
2026-09-08Favorite Annette FofficerSale2,817 @ $340.81$960K−14.3% of holdingnot yet — horizon still opennot yet — horizon still open16,845Form 4 · filed 2 days after the trade
2026-09-08Favorite Annette FofficerSale2,500 @ $340.81$852K−12.9% of holdingnot yet — horizon still opennot yet — horizon still open16,845Form 4 · filed 2 days after the trade
2026-04-27Favorite Annette FofficerSale2,817 @ $305.20$860K−14.3% of holding−1.4%not yet — horizon still open16,828Form 4 · filed 2 days after the trade
2026-04-27Winters ChadofficerSale896 @ $300.67$269K−37.0% of holding−1.4%not yet — horizon still open1,523Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

156 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-15Favorite Annette FofficerOption exercise2,52424,342Form 4
2026-09-15Favorite Annette FofficerOption exercise2,5240Form 4
2026-09-14Favorite Annette FofficerOption exercise2,50024,318Form 4
2026-09-14Favorite Annette FofficerOption exercise2,5002,524Form 4
2026-09-11Favorite Annette FofficerOption exercise2,50024,318Form 4
2026-09-11Favorite Annette FofficerOption exercise2,5005,024Form 4
2026-09-08Favorite Annette FofficerOption exercise2,81819,663Form 4
2026-09-08Favorite Annette FofficerOption exercise2,81719,662Form 4
2026-09-08Favorite Annette FofficerOption exercise2,50019,345Form 4
2026-09-08Favorite Annette FofficerOption exercise2,8172,818Form 4
2026-09-08Favorite Annette FofficerOption exercise2,8180Form 4
2026-09-08Favorite Annette FofficerOption exercise2,5007,524Form 4
2026-09-08Lagarde MicheldirectorAward / grant6,2006,200Form 4
2026-09-08Lagarde MicheldirectorAward / grant4,9504,950Form 4
2026-09-08Lagarde MicheldirectorAward / grant3,6003,600Form 4
2026-09-08Lagarde MicheldirectorAward / grant13,87913,879Form 4
2026-09-08Lagarde MicheldirectorAward / grant11,08111,081Form 4
2026-09-08Lagarde MicheldirectorAward / grant12,08812,088Form 4
2026-08-11McMahon Robert W.directorWithheld for tax2,7647,021Form 4
2026-08-11McMahon Robert W.directorWithheld for tax3463,429Form 4
2026-08-11McMahon Robert W.directorOption exercise7942,383Form 4
2026-08-11McMahon Robert W.directorOption exercise6,3552,119Form 4
2026-08-11McMahon Robert W.directorOption exercise7943,775Form 4
2026-08-11McMahon Robert W.directorOption exercise6,3559,784Form 4
2026-08-11McMahon Robert W.directorOption exercise6,3559,784Form 4
2026-08-11McMahon Robert W.directorOption exercise7943,775Form 4
2026-06-30HAUGEN JANET BRUTSCHEAdirectorAward / grant46307Form 4
2026-05-12Campbell Shane AldenofficerWithheld for tax135613Form 4
2026-05-12Campbell Shane AldenofficerWithheld for tax84274Form 4
2026-05-12Campbell Shane AldenofficerOption exercise4741,417Form 4
2026-05-12Campbell Shane AldenofficerOption exercise296886Form 4
2026-05-12Campbell Shane AldenofficerOption exercise296358Form 4
2026-05-12Campbell Shane AldenofficerOption exercise474748Form 4
2026-05-12Campbell Shane AldenofficerOption exercise296358Form 4
2026-05-12Campbell Shane AldenofficerOption exercise474748Form 4
2026-05-04Michels Douglas AdirectorAward / grant79146,496Form 4
2026-05-04FRIEL ROBERT FdirectorAward / grant7915,513Form 4
2026-05-04Feehery William FdirectorAward / grant79132,519Form 4
2026-05-04Pucci PaolodirectorAward / grant79111,854Form 4
2026-05-04BUTHMAN MARK AdirectorAward / grant79144,309Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.

As of 2026-09-16 · point-in-time by filed date

Purchase clusters · 2015–2021 (dev)+45 bp/mo vs baseline · up-rate 59.3% vs 57.3% · n=31,607 cluster ticker-weeks
Purchase clusters · 2022–2026 (out-of-sample)+32 bp/mo vs baseline · up-rate 54.0% vs 53.3% · n=27,793

A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).

'23 Q'24 Q'24 Q'24 Q'24 Q'25 Q'25 Q'25 Q'26 Q'26 Q'26 Qpurchases ▲ / sales ▼ ($ vol)
MemberChamberTypeFiledTradedSize
Ro KhannaHousesale2026-07-062026-06-02$1–15K
Ro KhannaHousesale2026-06-092026-05-27$1–15K
Ro KhannaHousesale2026-03-092026-02-05$1–15K
Ro KhannaHousepurchase2026-02-062026-01-29$1–15K
Lisa McclainHousesale2025-08-132025-07-22$1–15K
Lisa McclainHousepurchase2025-08-132025-06-17$1–15K
Ro KhannaHousepurchase2025-06-102025-05-19$1–15K
Ro KhannaHousepurchase2025-05-122025-04-23$1–15K
Rob BresnahanHousesale2025-05-082025-04-08$1–15K
Ro KhannaHousesale2025-04-102025-03-12$1–15K
Rob BresnahanHousepurchase2025-03-272025-02-25$1–15K
Jared MoskowitzHousesale2025-03-062025-02-13$1–15K
Ro KhannaHousesale2025-03-062025-02-19$1–15K
Jared MoskowitzHousesale2024-12-092024-11-08$1–15K

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.